Genetic risk for chronic fatigue syndrome
Description of the granted funding
The goal of this proposal is to understand underlying biological mechanisms behind chronic fatigue syndrome (CFS) and long-term symptoms from COVID-19 (LongCOVID) using genetics and epidemiology. A hallmark of CFS is debilitating fatigue, migrating pain, headache, fluctuating heart rate and dysautonomia. CFS diagnosis can follow infections or self-reported infection, and flu-like symptoms. Similarly, a characteristic in infection with SARS-CoV-2 is that some individuals with relatively mild infection develop long-term symptoms of severe fatigue, pain and dysautonomia similar to CFS. Currently, there is no cure and the treatment options are symptomatic. We will use genetic and epidemiology tools to explore the etiology of CFS and LongCOVID. The project has the potential to discover novel biological molecules, elucidate mechanisms from infections and autoimmunity on CFS and explore the disease burden from CFS and LongCOVID at the population level.
Show moreStarting year
2022
End year
2027
Granted funding
Related funding decisions
372129
Research costs of Academy Research Fellows(2025)
181 775 €
353812
Research costs of Academy Research Fellows(2022)
300 000 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Decision maker
Scientific Council for Biosciences, Health and the Environment
30.05.2022
30.05.2022
Other information
Funding decision number
350181
Fields of science
Genetics, developmental biology, physiology
Research fields
Perinnöllisyystiede
Identified topics
public health, occupational health